yingweiwo

Drug Metabolite

Drug Metabolite

Drug metabolites are created when a drug is metabolized into a different form that still has therapeutic effects. Active metabolites can be produced by drug metabolism redox reactions like heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations. In some rare circumstances, conjugation reactions can also produce an active metabolite. 

Drug Metabolite related products

Structure Cat No. Product Name CAS No. Product Description
N-Desmethyl zopiclone-d8 V72239 N-Desmethyl zopiclone-d8 1189805-43-3 N-Desmethyl zopiclone-d8 is the deuterium labelled form of Norzopiclone.
N-Methyl Palbociclib (impurity of palbociclib) V72153 N-Methyl Palbociclib (impurity of palbociclib) 571189-51-0 N-Methyl Palbociclib is an impurity of Palbociclib.
N-Methyl pemetrexed (Pemetrexed Impurity A) V72229 N-Methyl pemetrexed (Pemetrexed Impurity A) 869791-42-4 N-Methyl pemetrexed is an impurity in Pemetrexed.
N-Methyl-4-pyridone-3-carboxamide V72129 N-Methyl-4-pyridone-3-carboxamide 769-49-3 N-Methyl-4-pyridone-3-carboxamide is a metabolite of caffeopyridine.
N-Nitrosoglyphosate sodium (N-Nitroso-N-(phosphonoMethyl)glycine sodium; Glyphosate-N-nitroso sodium) V72226 N-Nitrosoglyphosate sodium (N-Nitroso-N-(phosphonoMethyl)glycine sodium; Glyphosate-N-nitroso sodium) 56516-71-3 N-Nitrosoglyphosate sodium is a degradation product of nitrosamines and a synthetic impurity in glyphosate herbicides.
Netupitant N-oxide-d6 V78373 Netupitant N-oxide-d6 Netupitant N-oxide-d6 is the deuterium labelled form of Netupitant N-oxide.
Niraparib metabolite M1 V3789 Niraparib metabolite M1 1476777-06-6 Niraparib metabolite M1 is a carboxylic acid metabolite of niraparib (MK4827; Zejula), which is a PARP1/2 inhibitor approved for cancer treatment.
Nordoxepin hydrochloride (Desmethyldoxepin hydrochloride) V72204 Nordoxepin hydrochloride (Desmethyldoxepin hydrochloride) 2887-91-4 Nordoxepin HCl is the major metabolite of doxepin.
Nordoxepin-d3 hydrochloride (Desmethyldoxepin-d3 (hydrochloride)) V72189 Nordoxepin-d3 hydrochloride (Desmethyldoxepin-d3 (hydrochloride)) 1331665-54-3 Nordoxepin-d3 ( HCl) is the deuterated form of Nordoxepin HCl.
Norendoxifen V50927 Norendoxifen 1308808-22-1 nonsteroidal aromatase inhibitor; tamoxifen metabolite
Norzopiclone (N-Desmethyl zopiclone; RP 32273) V72297 Norzopiclone (N-Desmethyl zopiclone; RP 32273) 59878-63-6 Norzopiclone is the inactive (non-active) metabolite of Zopiclone.
O-Demethyl Lenvatinib V72152 O-Demethyl Lenvatinib 417717-04-5 O-Demethyl Lenvatinib is a metabolite of Lenvatinib.
O-Demethyl Lenvatinib hydrochloride V76683 O-Demethyl Lenvatinib hydrochloride O-Demethyl Lenvatinib HCl is a metabolite of Lenvatinib.
O-desmethyl Mebeverine acid-d5 hydrochloride V80987 O-desmethyl Mebeverine acid-d5 hydrochloride O-desmethyl Mebeverine acid-d5 ( HCl) is the O-desmethyl Mebeverine acid deuterated compound standard.
O-Desmethyl Mebeverine alcohol hydrochloride (Mebeverine metabolite O-desmethyl Mebeverine alcohol hydrochloride) V71257 O-Desmethyl Mebeverine alcohol hydrochloride (Mebeverine metabolite O-desmethyl Mebeverine alcohol hydrochloride) 856620-39-8 O-Desmethyl Mebeverine alcohol HCl is a metabolite of Mebeverine, a potent α1 receptor (α1 receptor) inhibitor used as an antispasmodic drug in the digestive tract.
Ochratoxin α V72123 Ochratoxin α 19165-63-0 Ochratoxin α Ochratoxin A A low-toxic photolytic and thermal degradation product.
Olmesartan ethyl ester (olmesartan medoxomil ethyl ester impurity) V72255 Olmesartan ethyl ester (olmesartan medoxomil ethyl ester impurity) 144689-23-6 Olmesartan ethyl ester (compound 11) is an impurity of Olmesartan.
Omeprazole sulfide-d3 (Ufiprazole-d3) V72126 Omeprazole sulfide-d3 (Ufiprazole-d3) 922730-98-1 Omeprazole sulfide-d3 is the deuterium labelled form of Omeprazole sulfide.
Oseltamivir carboxylate (GS 4071; Ro 64 0802) V16457 Oseltamivir carboxylate (GS 4071; Ro 64 0802) 187227-45-8 Oseltamivir acid (GS 4071), the bioactive metabolite of Oseltamivir phosphate, is an orally bioavailable and selective inhibitor of influenza virus neuraminidase (IC50=2 nM), active against both influenza viruses A and B.
Osimertinib Impurity C(Rezivertinib analogue 1) V60038 Osimertinib Impurity C(Rezivertinib analogue 1) 2227103-37-7 Rezivertinib analog 1 is a process impurity in osimertinib mesylate and may be utilized in study/research of non-small cell lung cancer.
Contact Us